All Pharma News
Pierre Fabre Appoints Adriana Herrera CEO of New U.S. Affiliate

Pierre Fabre Appoints Adriana Herrera CEO of New U.S. Affiliate
CONTRACT PHARMA
04 Apr 2024
Share Share
Kinnate Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre

Kinnate Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre
GLOBENEWSWIRE
01 Mar 2024
Share Share
Pierre Fabre committed to combating rare pediatric diseases via therapies

Pierre Fabre committed to combating rare pediatric diseases via therapies
PR NEWSWIRE
23 Feb 2024
Share Share
Pierre Fabre and the EspeRare Foundation to be honored with the EURORDIS Award

Pierre Fabre and the EspeRare Foundation to be honored with the EURORDIS Award
PR NEWSWIRE
15 Feb 2024
Share Share
Atara and Pierre Fabre Announce Publication of Phase 3 ALLELE Tab-cel® Data

Atara and Pierre Fabre Announce Publication of Phase 3 ALLELE Tab-cel® Data
BUSINESSWIRE
31 Jan 2024
Share Share
Pierre Fabre Collaborates With Chowis Company

Pierre Fabre Collaborates With Chowis Company
ACCESSWIRE
24 Nov 2023
Share Share
Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories

Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories
BUSINESSWIRE
15 Nov 2023
Share Share
Pierre Fabre commits up to $640M in T-cell deal with Atara

Pierre Fabre commits up to $640M in T-cell deal with Atara
Kevin Dunleavy FIERCE PHARMA
04 Nov 2023
Share Share
EMA validates Pierre Fabre`s MAA for BRAFTOVI

EMA validates Pierre Fabre`s MAA for BRAFTOVI
PR NEWSWIRE
02 Nov 2023
Share Share
Scorpion and Pierre Announce First Patient Dosed in Phase 1/2 Trial of STX-721

Scorpion and Pierre Announce First Patient Dosed in Phase 1/2 Trial of STX-721
PR NEWSWIRE
10 Oct 2023
Share Share